share_log
Reuters ·  May 1 08:02
Lipocine: Confirmed With FDA Acceptance of Proposal for Nda Filing Enabled by Pivotal Pk Study Comparing Exposure of Lpcn 1154 With IV Infusion of Brexanolone
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment